The Pharmacogenomics Journal - Table of Contents alert Volume 17 Issue 2

If you are unable to see the message below, click here to view.

Advertisement NYU Nature Conference on Neurogenetics  August 9-11, 2017| New York, NY Presented by: New York University (NYU) | Nature Genetics | Nature Neuroscience  Register now! TABLE OF CONTENTS Volume 17, Issue 2 (March 2017) In this issue News and Commentary Review Original Articles Consensus Article Also new AOP Advertisement   A new open access journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine. Part of the Nature Partner Journals series, the journal is published in partnership with the Center of Excellence in Genomic Medicine Research.  Open for submissions >> Sign up for e-alerts Recommend to your library Web feed Subscribe   News and Commentary Top Tamoxifen metabolism in breast cancer treatment: Taking the focus off the CYP2D6 gene A Novillo, A Romero-Lorca, M Gaibar, M Rubio and A Fernández-Santander Pharmacogenomics J 2016 17: 109-111; advance online publication, October 4, 2016; 10.1038/tpj.2016.73 Full Text Review Top Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa OPEN J L Baker, D Shriner, A R Bentley and C N Rotimi Pharmacogenomics J 2016 17: 112-120; advance online publication, October 25, 2016; 10.1038/tpj.2016.78 Abstract | Full Text Original Articles Top Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment W C Tan-Koi, Evelyn S H Lim and Y Y Teo Pharmacogenomics J 2016 17: 121-127; advance online publication, February 23, 2016; 10.1038/tpj.2016.5 Abstract | Full Text Impact of germline and somatic missense variations on drug binding sites OPEN C Yan, N Pattabiraman, J Goecks, P Lam, A Nayak, Y Pan, J Torcivia-Rodriguez, A Voskanian, Q Wan and R Mazumder Pharmacogenomics J 2016 17: 128-136; advance online publication, January 26, 2016; 10.1038/tpj.2015.97 Abstract | Full Text Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines OPEN A Chhibber, C E French, S W Yee, E R Gamazon, E Theusch, X Qin, A Webb, A C Papp, A Wang, C Q Simmons, A Konkashbaev, A S Chaudhry, K Mitchel, D Stryke, T E Ferrin, S T Weiss, D L Kroetz, W Sadee, D A Nickerson, R M Krauss, A L George, E G Schuetz, M W Medina, N J Cox, S E Scherer, K M Giacomini and S E Brenner Pharmacogenomics J 2016 17: 137-145; advance online publication, February 9, 2016; 10.1038/tpj.2015.93 Abstract | Full Text The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis E Sacchetti, C Magri, A Minelli, P Valsecchi, M Traversa, S Calza, A Vita and M Gennarelli Pharmacogenomics J 2016 17: 146-154; advance online publication, February 9, 2016; 10.1038/tpj.2015.90 Abstract | Full Text A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate P S Chen, H H Chang, C-C Huang, C C Lee, S-Y Lee, S-L Chen, S-Y Huang, Y K Yang and R-B Lu Pharmacogenomics J 2016 17: 155-161; advance online publication, February 9, 2016; 10.1038/tpj.2015.96 Abstract | Full Text ABCC3 genetic variants are associated with postoperative morphine-induced respiratory depression and morphine pharmacokinetics in children V Chidambaran, R Venkatasubramanian, X Zhang, L J Martin, J Niu, T Mizuno, T Fukuda, J Meller, A A Vinks and S Sadhasivam Pharmacogenomics J 2016 17: 162-169; advance online publication, January 26, 2016; 10.1038/tpj.2015.98 Abstract | Full Text Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population C-C Chang, C-C Ng, C-L Too, S-E Choon, C-K Lee, W-H Chung, S H Hussein, K-S Lim and S Murad Pharmacogenomics J 2016 17: 170-173; advance online publication, March 1, 2016; 10.1038/tpj.2016.10 Abstract | Full Text A pharmacogenomic study on the pharmacokinetics of tacrolimus in healthy subjects using the DMETTM Plus platform Y Choi, F Jiang, H An, H J Park, J H Choi and H Lee Pharmacogenomics J 2016 17: 174-179; advance online publication, February 16, 2016; 10.1038/tpj.2015.99 Abstract | Full Text A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment H-W Park, S Tse, W Yang, H W Kelly, S C Kaste, C-H Pui, M V Relling and K G Tantisira Pharmacogenomics J 2016 17: 180-185; advance online publication, February 9, 2016; 10.1038/tpj.2015.92 Abstract | Full Text Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetes A Blasetti, C Di Giulio, S Tumini, M Provenzano, D Rapino, L Comegna, G Prezioso, R Chiuri, S Franchini, F Chiarelli and L Stuppia Pharmacogenomics J 2016 17: 186-191; advance online publication, February 23, 2016; 10.1038/tpj.2016.6 Abstract | Full Text A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials S de Denus, J L Rouleau, D L Mann, G S Huggins, T P Cappola, S H Shah, J Keleti, Y F Zada, S Provost, A Bardhadi, M S Phillips, V Normand, I Mongrain and M-P Dubé Pharmacogenomics J 2016 17: 192-200; advance online publication, March 1, 2016; 10.1038/tpj.2016.4 Abstract | Full Text ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout R L Roberts, M C Wallace, A J Phipps-Green, R Topless, J M Drake, P Tan, N Dalbeth, T R Merriman and L K Stamp Pharmacogenomics J 2017 17: 201-203; advance online publication, January 26, 2016; 10.1038/tpj.2015.101 Abstract | Full Text Consensus Article Top The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy Q Feng, W Q Wei, C P Chung, R T Levinson, L Bastarache, J C Denny and C M Stein Pharmacogenomics J 2016 17: 204-208; advance online publication, February 23, 2016; 10.1038/tpj.2016.3 Abstract | Full Text   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.